GSS genetic signatures limited

Global expansion post Covid 19, page-8

  1. 739 Posts.
    lightbulb Created with Sketch. 73
    This is now a contrarian view to think these molecular diagnostic can sustain top line growth after covid testing volume drops over time. Gss was growing well before covid and covid will only have accelerated its growth. I think this contrarian view will be profitable in the near future. Back the management who has been executing well time after time.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.0¢
Change
-0.005(1.45%)
Mkt cap ! $77.22M
Open High Low Value Volume
35.0¢ 35.0¢ 33.0¢ $19.92K 58.59K

Buyers (Bids)

No. Vol. Price($)
1 2689 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 14354 1
View Market Depth
Last trade - 15.37pm 28/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.